H.R. 7391In committeeHealth care
Bill requires upfront 340B discounts at health clinics
Data as of July 11, 2026
This bill requires drug companies to charge community health clinics the discounted 340B price upfront, not after a rebate process.45-second read · 4 questions answered below
Decoded
What does this do?
This bill requires that federally qualified health centers pay the discounted 340B drug price at the time of purchase. Drug manufacturers would no longer be allowed to charge full price at the register and refund the difference later. The rule applies to new drug purchases starting on the day the law takes effect and also applies to existing agreements with manufacturers.
Who does it affect?
Federally qualified health centers, which are community health clinics that serve low-income and underserved patients, are directly affected. The patients who rely on these clinics are also affected, since the clinics depend on immediate savings to fund their services.
Why does it matter?
Without upfront discounts, clinics must spend money they may not have and wait to get it back, which can strain their budgets. That strain can affect how well clinics are able to serve their communities.
Where does it stand?
- Introduced
- House committee — You are here
- House vote
- Senate
- President's desk
Right now: a House committee is reviewing it. If the Senate changes it, it goes back to the House before reaching the President.
AI-drafted summary. Verify it against the official text before you act on it.
Three steps: where you stand, your script, the call.
Make the callSee how a call works
Official title
Community Health Center Drug Pricing Protection Act
- Introduced:
- February 5, 2026
- Latest action:
- February 5, 2026
Referred to the House Committee on Energy and Commerce.
Read the official bill on Congress.govMake the call
Three steps: where you stand, your script, the call.